Adequacy of the Dosing and Infusion Time of Ceftazidime/Avibactam for the Treatment of Gram-Negative Bacterial Infections: A PK/PD Simulation Study.
Yun HanJianping ZhuJieqiong LiuYing ZhengGang LiangYi YangLingyan YuZhenwei YuGang HanPublished in: Infection and drug resistance (2024)
The current recommended dosing regimen of ceftazidime/avibactam is insufficient for severe infection patients, and continuous infusion is suggested.